Related Experiment Video
Updated: Aug 22, 2025

11:52
Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
3.2K
Non-Antibiotic Antimony-Based Antimicrobials
Nikolay Gerasimchuk1, Kevin Pinks1, Tarosha Salpadoru2
1Department of Chemistry and Biochemistry, Temple Hall 456, Missouri State University, Springfield, MO 65897, USA.
Molecules (Basel, Switzerland)
|November 11, 2022
Summary
New organoantimony(V) cyanoximates show potential as non-antibiotic antimicrobial agents. The antimony phenyl group (SbPh4) was crucial for activity against resistant bacterial and fungal pathogens.
Area of Science:
- Organometallic Chemistry
- Medicinal Chemistry
- Antimicrobial Research
Background:
- Increasing antimicrobial resistance necessitates novel therapeutic agents.
- Organoantimony compounds have shown diverse biological activities.
- Cyanoximes are a class of oximes with potential biological applications.
Purpose of the Study:
- To synthesize and characterize novel organoantimony(V) cyanoximates.
- To investigate the potential of these compounds as non-antibiotic antimicrobial agents against resistant pathogens.
Main Methods:
- Heterogeneous metathesis reaction for synthesis.
- Spectroscopic and physical methods for characterization.
- X-ray crystallography for structural determination.
- Antimicrobial susceptibility testing against bacterial and fungal pathogens.
Main Results:
- Eight novel organoantimony(V) cyanoximates with the composition Sb(C6H5)4L were successfully synthesized.
- Crystal structures revealed a distorted trigonal bipyramidal environment around the antimony atom.
- The compounds demonstrated significant broad- and narrow-spectrum antimicrobial activity against tested bacterial (Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus) and fungal (Cryptococcus neoformans, Candida albicans) pathogens.
- The SbPh4 group was essential for the observed antimicrobial effect.
Conclusions:
- The synthesized organoantimony(V) cyanoximates represent a promising new class of non-antibiotic antimicrobial agents.
- These findings provide a basis for further structural modifications to enhance antimicrobial potency.
- The study highlights the potential of organoantimony compounds in combating drug-resistant infections.
Related Concept Videos
Chemical Agents for Microbial Control
172
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
172
Antimicrobial Effectiveness
134
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
134
Antimicrobial Proteins
3.2K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
3.2K
Surface Membrane Barriers
1.3K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.3K
Hand hygiene
3.6K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Hand washing...
3.6K
Antidotes
739
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
739

